|Articles|January 1, 1997

January 1997
Volume 3
Issue 1

To Tell the Truth: Disclosing the Incentives and Limits of Managed Care

Author(s)E. Haavi Morreim, PhD

Download PDF: To Tell the Truth: Disclosing the Incentives and Limits of Managed Care

Articles in this issue

about 29 years ago

Article

Correspondence regarding, "The Psychopharmacology of Depression in the Managed Care Setting"

about 29 years ago

Article

Implications of Managed Care Denials for Pediatric Inpatient Care

about 29 years ago

Article

Cost-Effectiveness of Sumatriptan in a Managed Care Population

about 29 years ago

Article

A Cost-Effective Approach to the Use of Selective Serotonin Reuptake Inhibitors in a Veterans Affairs Medical Center

about 29 years ago

Article

An Innovative Approach to Reducing Medical Care Utilization and Expenditures

about 29 years ago

Article

The Relationship and Tensions Between Vertical Integrated Delivery Systems and Horizontal Specialty Networks

about 29 years ago

Article

Managed Care Organizations Should Not Disclose Their Physicians' Financial Incentives

about 29 years ago

Article

Theoretical Framework for Implementing a Managed Care Curriculum for Continuing Medical Education -- Part I

about 29 years ago

Article

Application of the Problem-Based Learning Model for Continuing Professional Education: A Continuing Medical Education Program on Managed Care Issues -- Part II

about 29 years ago

Article

Bridging the Gap Between Managed Care and Academic Medicine: An Innovative Fellowship

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

To Tell the Truth: Disclosing the Incentives and Limits of Managed Care

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

5 Things to Know About the Oral GLP-1 Era

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention